Development and validation of spectrophotometric methods for determination of ceftazidime in pharmaceutical dosage forms.
Two spectrophotometric methods for the determination of ceftazidime (CFZM) in either pure form or in its pharmaceutical formulations are described. The first method is based on the reaction of 3-methylbenzothiazolin-2-one hydrazone (MBTH) with ceftazidime in the presence of ferric chloride in acidic medium. The resulting blue complex absorbs at lambdamax 628 nm. The second method describes the reaction between the diazotized drug and N-(1-naphthyl)ethylenediamine dihydrochloride (NEDA) to yield a purple colored product with lambdamax at 567 nm. The reaction conditions were optimized to obtain maximum color intensity. The absorbance was found to increase linearly with increasing the concentration of CFZM; the systems obeyed the Beer's law in the range 2-10 and 10-50 microg mL-1 for MBTH and NEDA methods, resp. LOD, LOQ and correlation coefficient values were 0.15, 0.79 and 0.50, 2.61. No interference was observed from common excipients present in pharmaceutical formulations. The proposed methods are simple, sensitive, accurate and suitable for quality control applications.
Hiremath
Basavaraj
B
Department of Chemistry, Gulbarga University, Gulbarga-585106, India.
Mruthyunjayaswamy
Bennikallu Hire Mathada
BH
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000032:analysis*; D052160:Benzothiazoles / Q000737:chemistry; D002442:Ceftazidime / Q000008:administration & dosage / Q000032:analysis*; D002626:Chemistry, Pharmaceutical; D002712:Chlorides; D004304:Dosage Forms; D005029:Ethylenediamines / Q000737:chemistry; D005079:Excipients / Q000737:chemistry; D005290:Ferric Compounds / Q000737:chemistry; D006835:Hydrazones / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D007267:Injections; D015203:Reproducibility of Results; D013053:Spectrophotometry; D013678:Technology, Pharmaceutical / Q000379:methods*
D000900:Anti-Bacterial Agents; D052160:Benzothiazoles; D002712:Chlorides; D004304:Dosage Forms; D005029:Ethylenediamines; D005079:Excipients; D005290:Ferric Compounds; D006835:Hydrazones; C008588:N-(1-naphthyl)ethylenediamine; D002442:Ceftazidime; C002536:3-methyl-2-benzothiazolone hydrazone; C024555:ferric chloride